Skip to content
Review Open access

Clinical outcomes of revision anterior cruciate ligament reconstruction with and without a lateral extra-articular procedure: A systematic review and meta-analysis.

Nov 2026 · Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine · Vol 21, pp. 101241 · 0 citations
Medicine

Abstract

Importance

Revision anterior cruciate ligament reconstruction (R-ACLR) has less favorable outcomes than primary reconstruction. Earlier revision-specific meta-analyses included eight and ten comparative studies. The clinical value of adding a lateral extra-articular procedure (LEAP) remains uncertain.

Objective

This study aimed to compare clinical outcomes after R-ACLR performed with versus without LEAP augmentation. EVIDENCE REVIEW PubMed, Embase, and Web of Science were searched from January 1, 2006, to April 30, 2026. Comparative studies reporting clinical follow-up of at least 24 months were eligible; the randomized trial also supplied objective stability measurements at 1 year. Random-effects meta-analyses evaluated function, stability, failure or rerevision, and return to activity. Methodological quality and certainty were assessed using the Downs and Black checklist and the Grading of Recommendations Assessment, Development and Evaluation framework.

Findings

Fourteen studies included 1134 patients (559 with LEAP and 575 with isolated R-ACLR). The failure analysis included 11 studies and 1023 patients: 29/517 versus 69/506 events (risk ratio [RR], 0.44; 95% confidence interval [CI], 0.29-0.68; P < 0.001; I2 = 3.9%). Certainty in this combined estimate was very low. LEAP augmentation was associated with less anterior laxity (Hedges' g, 0.46; 95% CI, 0.21-0.71) and fewer positive pivot shifts (RR, 0.51; 95% CI, 0.30-0.87). The subjective International Knee Documentation Committee score difference was small (mean difference, 2.91; 95% CI, 0.23-5.59). Return to any sport was informed by only two studies and 87 patients (RR, 1.10; 95% CI, 0.92-1.32; P = 0.278).

Conclusion

AND RELEVANCE LEAP augmentation was associated with lower observed failure or rerevision risk and greater postoperative stability. Patient-reported differences were small and inconsistent. Predominantly nonrandomized evidence and very low certainty in the combined estimates limit causal inference and subgroup recommendations. LEVEL OF EVIDENCE Level III. REGISTRATION International Prospective Register of Systematic Reviews, CRD420261441628.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.